KWESST to Provide General Corporate Update Next Week with Results of Annual and Special Meeting of Shareholders
Ottawa, Ontario–(Newsfile Corp. – March 31, 2023) – KWESST Micro Systems Inc. (NASDAQ: KWE) (NASDAQ:…
Ottawa, Ontario–(Newsfile Corp. – March 31, 2023) – KWESST Micro Systems Inc. (NASDAQ: KWE) (NASDAQ:…
JAKARTA, Apr 1, 2023 – (ACN Newswire) – Indonesia’s Ministry of Communications and Informatics (MCI)…
Its Robust Capital Improvements Investments Continue HOUSTON–(BUSINESS WIRE)–The Port Commission of the Port of Houston…
SEATTLE–(BUSINESS WIRE)–#ConsiderITDone–Zones has been identified as a key player in the “Future of Work” for…
PowerSchool Unified Classroom® recognized as a winner in the learning management system (LMS) category FOLSOM,…
Denver, CO (March 30, 2023) – TermScout, the AI-based contract data and review company, today…
Company Also Restructures Existing Kreos Loan, Deferring Over $3 Million of Repayment PETACH TIKVA, Israel, March…
Company announcement – No. 12 / 2023 Total number of shares and voting rights in…
NEW YORK, March 31, 2023 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (“Better Choice”…
Companies Welcome Approval by Minister of Innovation, Science and Industry for the Transfer of Shaw’s…
AMSTERDAM, Mar 31, 2023 – (ACN Newswire) – To prove how easy it is for…
HONG KONG, Mar 31, 2023 – (ACN Newswire) – Sino Biopharmaceutical Limited (“Sino Biopharm” or…
(30th March 2023, Knowsley, Merseyside, UK.) At the forefront of innovating automated post-processing technologies specifically…
New York, New York–(Newsfile Corp. – March 31, 2023) – Starfleet Innotech, Inc. (OTC Pink:…
New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact…
New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact…
Completed Enrollment in INOpulse® REBUILD Phase 3 trial; Pivotal Top-line Data Expected in Mid-2023 Signed…
Completed Enrollment in INOpulse® REBUILD Phase 3 trial; Pivotal Top-line Data Expected in Mid-2023 Signed…
YONKERS, N.Y., March 31, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
YONKERS, N.Y., March 31, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…